
Stephen A. Strickland/sarahcannon.com
Apr 29, 2025, 09:16
Navneet Majhail: Congratulations to Stephen Strickland for presenting first-in-human results of SENTI-202
Navneet Majhail, Physician-in-Chief of Blood Cancers at the Sarah Cannon Transplant and Cellular Therapy Network, shared a post on LinkedIn:
“Congratulations to Stephen Strickland from Sarah Cannon Research Institute at TriStar Centennial Medical Center, Nashville for presenting first-in-human results of SENTI-202, a CD33/FLT3 selective off-the-shelf logic gated CAR NK cell therapy, in hematologic malignancies including AML at the AACR25 meeting.
Also appreciate the work from our investigators at Sarah Cannon Cancer Network Transplant and Cellular Therapy Programs in San Antonio (Dr Nosha Farhadfar) and Denver (Dr Ali Eghtedar) who are serving as co-authors on the abstract.”
More posts featuring Navneet Majhail.
AACR25
Ali Eghtedar
AML
cancer
CAR-NK cell therapy
CD33/FLT3
Denver
fight against cancer
Global fight against cancer
Navneet Majhail
Nosha Farhadfar
OncoDaily
Oncology
San Antonio
Sarah Cannon Research Institute
Sarah Cannon Transplant and Cellular Therapy Network
SENTI-202
Stephen Strickland
TriStar Centennial Medical Center
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Apr 29, 2025, 10:37
Apr 29, 2025, 10:28
Apr 29, 2025, 10:18
Apr 29, 2025, 10:16
Apr 29, 2025, 10:07
Apr 29, 2025, 09:54